The clinical observation of inhaling salbutamol before painless bronchoscopy in children with mycoplasma pneumonia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025281

Enrollment

Unknown

Registered

2019-08-20

Start date

2019-09-30

Completion date

Unknown

Last updated

2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mycoplasma pneumonia

Interventions

experimental group:Inhaled albuterol before bronchoscopy combined with conventional drugs

control group:conventional drugs

Eligibility

Sex/Gender

All

Age

1 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. The children with mycoplasma pneumoniae who underwent fiberbronchoscopy in Children's Hospital of Chongqing Medical University 2. Aged 1-10 years, in supine position. 3. ASA II to III.

Exclusion criteria

Exclusion criteria: 1. Children with severe other systemic diseases before surgery. 2. Children who cannot complete the examination with spontaneous breathing after intravenous combined anesthesia.

Design outcomes

Primary

Measure	Time frame
the times of tracheal spasm;Check pause times;	—

Countries

China

Contacts

Public ContactYing Xu

Children's Hospital of Chongqing Medical University

xuyingxy3066@126.com+86 13983409393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026